Nucleosys Tech Competitors

The agency where curiosity builds change. We are in the business of real change—the kind that drives earlier diagnoses, accelerates adoption of breakthrough therapies, and ultimately delivers better health and better outcomes. Real change happens when beliefs shift. When science, story, and strategy converge in exactly the right way—in the head and the heart. We fuse evidence and emotion—never choosing between them—to develop captivating, belief-shifting experiences that move markets and move hearts. We are more than an HCP or patient agency. Our full-service, omnichannel capabilities span high-stakes, therapeutic categories, powered by a team of curious minds, brave hearts, and ready hands. We push one another to uncover truths, discover potential, and create energy that moves the needle forward. If you're ready to cultivate curiosity, speak with courage, and make a real difference in healthcare, explore our open positions. We're looking for people who want to build change alongside us.

Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer. Its end-to-end technology platform is built on multiple proprietary exclusive product development and product enhancement technologies, and allows Medigene to create best-in-class differentiated, T cell receptor engineered T cell (TCR-T) therapies for multiple solid tumor indications that are optimized for both safety and efficacy. This platform provides product candidates for both its in-house therapeutics pipeline and partnering. For more information, please visit www.medigene.com

Precision Genetics provides full-scale lab and genetics testing solutions including COVID, and pharmacogenomics (PGx) for perioperative and mental health to improve overall patient outcomes. By combining evidence-based technology and population risk analysis into a comprehensive and actionable solution, we allow busy providers to immediately deliver individualized treatment and prevention plans for their patients. Additionally, we allow employers to see the benefits of lowering costs around both prescription- spending and overall healthcare while employing a healthier, more engaged staff. This comprehensive, personalized approach reduces interaction and efficacy risks while ensuring proper medications are being used for therapies. Precision Genetics combines genetic markers, molecular data, and clinical evidence into a comprehensive and actionable report, allowing busy physicians and providers to immediately develop individualized treatment and prevention plans for their patients. This comprehensive, personalized approach reduces interaction and efficacy risks while assuring proper therapy. Our interactive tools empower patients to utilize their molecular results to address their individual risks and treatment pathways based on their unique genetics, demographics, lifestyle, and medical conditions. Most importantly, a patient’s genetic risk analysis can be applied later in life as their risks increase; their health changes or new treatment pathways are identified.